European Healthtech startup funding raised during 2010.
In 2010, 44 European Healthtech companies raised a combined €346M across 45 funding rounds. France led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 7 Aug 2026.
1 exit · €155M disclosed.
| Endosense |
| Acquisition |
| May 2010 |
| €155M |
| €25M |
| WILEX | Other | Mar 2010 | €24M |
| Oxford Nanopore Technologies | Series C | Apr 2010 | €21M |
| CeQur | Series A | Jan 2010 | €21M |
| NovImmune | Series D+ | Dec 2010 | €17M |
| Genticel | Series C | Apr 2010 | €13M |
| Valtech Cardio | Series B | Mar 2010 | €13M |
| EarlySense | Series C | Jul 2010 | €11M |
| uTest_Vamsi | Series C | Sep 2010 | €10M |
| Protagen | Series B | Sep 2010 | €10M |
| Nanobiotix | Other | May 2010 | €9.9M |
| Funxional Therapeutics | Series B | May 2010 | €9.2M |
